Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK and Safety of Levosulpiride in Healthy Chinese Volunteers
NCT02481583Phase 1Completed
- Start
- Mar 2013
- Primary completion
- May 2013
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, open-label trial of levosulpiride in dyspepsia (2 arms). Primary endpoints: Maximum Plasma Concentration at 2 days, Area Under the Curve at 2 days and 2 more. Started Mar 2013; status: completed.
02
Drugs
levosulpiride
03
Conditions
dyspepsia
Beyond the preview
Go deeper on NCT02481583.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02481583.